This site is made to provide information about recently started Pharm D and Pharm D(Post Bacclaurreatte) courses in india to all
Saturday, 20 April 2024
A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector
A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Therefore requirement of a new course like Pharm D / Pharma D (PB), which will produce professionals called Pharmacist and Pharmacotherapist.
Thursday, 18 April 2024
Thursday, 22 February 2024
So many regulatory bodies and governing bodies in pharmacy education: whims of my mind
PCI(Pharmacy Council Of India) and AICTE(All India Council for technical education) are the governing bodies in the pharmacy education , keeping in mind the compounding and dispensing as well as the technical aspects involved in Pharmaceutical Engineering .
Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.
As it requires an affiliation with a hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India) also to get involved as a regulatory and governing body.
PCI governs courses like : D.Pharm
B.Pharm
Pharm D and Pharm D(PB)
AICTE governs courses like : B.Pharm( jointly with PCI)
M.Pharm
Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)
But no, its not a rational thinking on my part. MCI will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI is not involved into these matters.
Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.
As it requires an affiliation with a hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India) also to get involved as a regulatory and governing body.
PCI governs courses like : D.Pharm
B.Pharm
Pharm D and Pharm D(PB)
AICTE governs courses like : B.Pharm( jointly with PCI)
M.Pharm
Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)
But no, its not a rational thinking on my part. MCI will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI is not involved into these matters.
Labels:
PHARM D(PB) issues
Sunday, 11 February 2024
PHARMACIST IN HEALTHCARE/PHARMACARE
PHARMACIST IN HEALTHCARE.
Unless Indian healthcare service and infrastructure is made inclusive of pharmacy and pharmacists service, there is no scope for pharmacist in healthcare
Tuesday, 6 February 2024
High-Risk Drugs
High-Risk Drugs
"High risk medicines are those medicines that have a high risk of causing significant patient harm or death when used in error.- Google search
Although errors may or may not be more common than with other medicines, the consequences of errors with these medicines can be more devastating" - Google search.
"A – Antimicrobials
P – Potassium and other electrolytes, psychotropic medications
I – Insulin
N – Narcotics, opioids and sedatives
C – Chemotherapeutic agents
H – Heparin and other anticoagulants
S – Safer systems (e.g. safe administration of liquid medications using oral syringes)
Methods to reduce error include strategies such as:
👉 improving access to information about these drugs
👉 limiting access to high risk medications
👉 using Tallman* lettering to differentiate high risk medications
using auxiliary labels and automated alerts
👉 standardising the prescription, storage, preparation, and administration of these products."
------------
*Tallman lettering:
1.acetaZOLAMIDE vs. acetoHEXAMIDE.
2. buPROPion vs. busPIRone.
3.chlorproMAZINE vs. chlorproPAMIDE.
5.clomiPHENE vs. clomiPRAMINE.
6. cycloSERINE vs. cycloSPORINE."
- Google search.
Pharmacists should recollect their lessons on Routes of Administration, Times of Administration, LASA drug names and Importance of Administration by Medical attendant or under Medical supervision.
Identifying and self regulating them by Retail Pharmacists looks highly imminent Now in Public Interest.
Attn. #Pharmacists &
#DrugsInspectors
Tuesday, 30 January 2024
DTAB proposed to GoI an amendment to Sch K to circumvent all such judicial orders. Our representatives from PCI and IPA (Big) agreed to it for a cup of Tea!
DTAB proposed to GoI an amendment to Sch K to circumvent all such judicial orders.
Our representatives from PCI and IPA (Big) agreed to it for a cup of Tea!
Dispensing Of Medicines Under Doctor Without Pharmacist: High Court Stays Government Order
By Farhat NasimPublished On 15 Dec 2019 3:28 PM | Updated On 15 Dec 2019 3:28 PM
The court, subsequently held that the orders were unsustainable under the law and ordered the government to ensure that medicines were dispensed through qualified pharmacists
Kochi: The Kerala Government's order that approved dispensing of drugs under the supervision of medical practitioner in the absence of pharmacists at the government hospital pharmacies has come to a halt as the High Court recently issued a stay order.
The stay order was issued by Justice P B Suresh following a petition filed by All Kerala Pharmacists Union (AKPU), who submitted that only a registered pharmacist shall dispense any medicine as per Section 42 of Pharmacy Act, 1948.
The pharmacists union saw red after the state government issued an order that empowered the doctors/medical officers to dispense medicines under his/her direct supervision in case the pharmacist is absent from the hospital pharmacy or if he leaves the pharmacy. This was issued by the government in complying with the verdict passed by the high court in 2017. The 2017 case related to a statement by the Director of Health Services (DHS) allowing distribution of medicines through unqualified pharmacists.
As per a recent TOI report, the petitioner contended that in 2013, DHS had issued a circular pointing out that unqualified persons performing duties of pharmacists in government hospitals are in violation of the law. When Pharmacy Practice Regulations, 2015 came into being, the government issued a circular for its strict implementation and to prevent dispensing of medicines by unqualified persons.
However, in 2016, the DHS issued 2 orders for distributing medicines for non-communicable diseases (NCDs) to sub-centre clinics and allowing junior public health nurses to dispense NCD medicines, the petitioner added.
After hearing the entire case, the court subsequently held that the orders were unsustainable under the law and ordered the government to ensure that medicines were dispensed through qualified pharmacists, reports TOI.
Tuesday, 23 January 2024
Subscribe to:
Posts (Atom)